All 1 tracked stories fall under one category: fda-approval. Blockchain is most often covered alongside AIIMS-CAPFIMS, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Blockchain, all published on July 6, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Blockchain
All 1 tracked stories fall under one category: fda-approval. Blockchain is most often covered alongside AIIMS-CAPFIMS, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Blockchain, all published on July 6, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Blockchain. Shared-story counts are live from our verified record — not editorial picks.
By filling 460+ faculty posts, AIIMS significantly expands its research capacity, positioning itself for breakthroughs in biomedical science. The influx of professors and early-career researchers will drive clinical trials, publications, and innovation, supported by a transparent blockchain-based selection process.